Features of defeat of ent organs at adult patients with CF
https://doi.org/10.21518/2079-701X-2019-8-48-53
Abstract
Among diseases of ENT organs at patients with the CF prevails chronic rhinosinusitis. Stagnation of the infected dense slime in the paranasal sinus and violation of nasal breath aggravates weight of a course of lung pathology. Timely inspection and treatment of pathology of the top airways at patients with CF is necessary. In surgical treatment method of a choice is expanded FESS. This technique allows to keep anatomy of a facial skeleton and to provide a drainage the paranasal sinus. Supervision by the ENT specialist and conservative treatment of a chronic rhinosinusitis has to is carried out during all life of the patient with CF. Continuous use of local mukolitichesky and antibacterial therapy is necessary. As method of delivery of medicines the compressor inhaler with the mode for the chronic rhinosinusitis can serve.
About the Authors
V. M. Svistushkin
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med), Professor, Head of the Department of Ear, Throat and Nose Diseases, Federal State Autonomous Educational Institution of Higher Education «First Moscow State Medical University named after I.M. Sechenov», Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Dr. of Sci. (Med), Professor, Head of the Department of Ear, Throat and Nose Diseases, Federal State Autonomous Educational Institution of Higher Education «First Moscow State Medical University named after I.M. Sechenov», Ministry of Health of the Russian Federation (Sechenov University)
E. V. Sinkov
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Candidate of Medical Sciences, Associate Professor of the Department of Ear, Throat and Nose Diseases of the Federal State Autonomous Educational Institution of Higher Education «I.M. Sechenov First Moscow State Medical University» of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Candidate of Medical Sciences, Associate Professor of the Department of Ear, Throat and Nose Diseases of the Federal State Autonomous Educational Institution of Higher Education «I.M. Sechenov First Moscow State Medical University» of the Ministry of Health of the Russian Federation (Sechenov University)
G. L. Shumkova
Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of
the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Postgraduate student of the Department of Ear, Throat and Nose Diseases of the Federal State Autonomous Educational Institution of Higher Education of the First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Researcher at the Cystic Fibrosis Center of the Federal State Budgetary Institution «Research Institute of Pulmonology of the Federal Medical and Biological Agency» on the basis of the State Budgetary Institution of Healthcare of Moscow «D.D. Pletnev City Clinical Hospital of the Department of Healthcare of Moscow»
Russian Federation
Postgraduate student of the Department of Ear, Throat and Nose Diseases of the Federal State Autonomous Educational Institution of Higher Education of the First Sechenov Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Researcher at the Cystic Fibrosis Center of the Federal State Budgetary Institution «Research Institute of Pulmonology of the Federal Medical and Biological Agency» on the basis of the State Budgetary Institution of Healthcare of Moscow «D.D. Pletnev City Clinical Hospital of the Department of Healthcare of Moscow»
E. L. Amelina
Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»
Russian Federation
Cand. of Sci. (Med.), Deputy Head of the Cystic Fibrosis Laboratory, the Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»
Russian Federation
Cand. of Sci. (Med.), Deputy Head of the Cystic Fibrosis Laboratory, the Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»
S. A. Krasovsky
Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»
Russian Federation
Cand. of Sci. (Med.), Senior Researcher, the Cystic Fibrosis Laboratory, the Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»; a pulmonologyst, the 2nd Pulmonology Department of the State Budgetary Institution of Healthcare of the city of Moscow «Pletnev City Clinical Hospital of the Department of Health of Moscow»; Senior Researcher, the Research Clinical Cystic Fibrosis Department, the Federal State Budgetary Research Institution «Medical Genetic Research Center»
Russian Federation
Cand. of Sci. (Med.), Senior Researcher, the Cystic Fibrosis Laboratory, the Federal State Budgetary Institution «Research Institute for Pulmonology of the Federal Medical Biological Agency»; a pulmonologyst, the 2nd Pulmonology Department of the State Budgetary Institution of Healthcare of the city of Moscow «Pletnev City Clinical Hospital of the Department of Health of Moscow»; Senior Researcher, the Research Clinical Cystic Fibrosis Department, the Federal State Budgetary Research Institution «Medical Genetic Research Center»
References
1. Tandon R., Derkay C. Contemporary Management of Rhinosinusitis and Cystic Fibrosis. Curr Opin Otolaryngol Head Neck Surg. 2003;11(1):41-4.
2. Kapranov N., Kashirskaya N. Cystic fibrosis. Moscow: ID «Medpraktika-M» 2014; 672 p.] (In Russ.)
3. Krasovsky S., Chernyak A., Voronkov A., et al. Register of patients with cystic fibrosis in the Russian Federation. Moscow: ID «Medpraktika-m» 2018; 64 p.] (In Russ.)
4. Berkhout M.C., Van Rooden C.J., Rijntjes E., et al. Sinonasal manifestations of cystic fibrosis: A correlation between genotype and phenotype? J Cyst Fibr. 2014;13:442-448.
5. Hamilos D.L. Nasal and sinus problems in cystic fibrosis patients. In: Bachert C, Bourdin A, Chanez P. The Nose and Sinuses in Respiratory Disorders (ERS Monograph). Sheffield, European Respiratory Society, 2017:48–66. https://doi.org/10.1183/2312508X.10009616.
6. McKone E., Goss C., Aitken M. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest. 2006;130(5):1441-1447.
7. Woodworth B.A., Ahn C., Flume P.A., Schlosser R.J.. The delta F508 mutation in cystic fibrosis and impact on sinus development. Am J Rhinol Allergy. 2007;21(1):122-127.
8. Wang X., Moylan B., Leopold D. et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA. 2000 Oct. 11;284(14):1814-1819.
9. Oomen K.P., April M.M.. Sinonasal manifestations in cystic fibrosis. International Journal of Otolaryngology. 2012;2012:789572.
10. Henriksson G., Westrin K.M., Karpati F. et al. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002;121(1):40–47.
11. Svistushkin V.M., Nikiphorova G.N., Pshonkina D.M. Some aspects of the problem of chronic rhinosinusitis. Physician, medical research portal. https://w ww.lvrach.ru/2017/10/15436816/] (in Russ.)
12. Jerger J., Neely J.G. Audiometric testing. Arch Otolaryngology. 1971;93:111-112.
13. Bariljak V.V. Status hearing in children with cystic fibrosis. PhD Thesis. Moscow: 2012; 29 p.] (In Russ.)
14. Forman-Franco B., Abramson A.L., Gorvoy J.D., Stein T. Cystic fibrosis and hearing loss. Arch Otolaryngology. 1979;105:338-42.
15. Fritze W., Gotz M., Stur O., Zweymuller E. Hearing defects in cystic fibrosis. Z. Kinder-Heilk. 1973;114:111-118.
16. Thomé D.C., Tomikowa S.O., Romano F. et al. Manifestações nasossinusais em pacientes com fibrose cística (FC). Jornal Brasileiro de Pneumologia. 2006;32(1):5.
17. Steinke J.W., Payne S.C., Chen P.G. et al. Etiology of nasal polyps in cystic fibrosis: not a unimodal disease. Annals of Otology, Rhinology, and Laryngology. 2012;121(9):579–586.
18. Cimmino M., Cavaliere M., Nardone M. et al. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis. Clinical Otolaryngology Allied Sci. 2003;28(2):125–132.
19. Schwachman H., Kulczyckii L.L., Mueller H.L. et. al. Nasal polyposis in patients with cystic fibrosis. Pediatrics. 1962;30:389-401.
20. Henriksson G., Hestrin K.M., Karpati F. et al. Nasal Polyps in Cystic Fibrosis. Chest. 2002;121:40-47.
21. Berkhout M.C., Klerx-Melis F., Fokkens W.J. et al. CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with cystic fibrosis. J Cyst Fibros. 2016;15:816–824.
22. Berkhout M.C., Rijntjes E., El Bouazzaoui L.H. et al. Importance of bacteriology in upper airways of patients with Cystic Fibrosis. J Cyst Fibros. 2013;12:525-529.
23. Chernukha M.Y., Avetisyan L.R., Shaginyan I.A. et al. Algorithm of microbiological Diagnostics of chronic lung infections in cystic fibrosis patients. Moscow: ID «Medpraktika-M». 2016; 72 p.] (In Russ.)
24. Muhlebach M.S., Miller M.B., Moore C. et al. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol. 2006;41(5):445-51.
25. Godoy J.M., Godoy A.N., Ribalta G. et al. Bacterial pattern in chronic sinusitis and cystic fibrosis. Otolaryngology–Head and Neck Surgery. 2011:145–146.
26. Boutin S., Graeber S. Y., Weitnauer M. Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis. Journal of Cystic Fibrosis. 2010;10(5):121–125.
27. Chernukha M.Y., Shaginyan I.A, Kapranov N.I. et al. Persistence of Burchorderia cepacia in cystic fibrosis patients. ZhMJI. 2012;4:93-98.] (In Russ.)
28. Johansen H.K., Aanaes K., Pressler T. et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibr. 2012;11(6):525–531.
29. Wise S.K., Kingdom T.T., McKean L. et al. Presence of Fungus in Sinus Cultures of Cystic Fibrosis. American Journal of Rhinology. 2005;19(1):47-51.
30. Rosenstein B.J., Cutting G.R. The diagnosis of cystic fibrosis: a consensus statement. Journal of Pediatrics. 1998;132:589-595.
31. Nick J.A., Rodman D.M.. Manifestations of Cystic Fibrosis Diagnosed in Adulthood. Curr Opinion Pulm Med. 2005;11(6):513-8.
32. Mainz J.G., Koitschev A. Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asth Reports. 2012;12(2):163– 174.
33. Steinke J.W., Spencer D.Ph., Payne C. et al. Etiology of Nasal Polyps in Cystic Fibrosis: Not a Unimodal Disease. Ann Otol Rhinol Laryngol. 2012;121(9):579–586.
34. Eggesbø H.B., Søvik S., Dølvik S. et al. CT Characterization of Inflammatory Paranasal Sinus Disease in Cystic Fibrosis. Acta Radiologica. 2002;43(1):21-8.
35. Bock J.M., Schien M., Fischer C. Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients. Pediatr Pulmonol. 2017;39(1):11-14.
36. Tandon R., Derkay C.. Contemporary Management of Rhinosinusitis and Cystic Fibrosi. Curr Opin Otolar Head Neck Surg. 2003;11(1):41-44.
37. Albritton F.D., Kingdom T.T. Endoscopic Sinus Surgery in Pacients with Cystic Fibrosis: an Analysis of Complications. Amer J Rhinol. 2000;14(6):379-385.
38. Krzeski A., Kapiszewska-Dzedzej D., Jakubczyk I. Extent of Pathological Changes in the Paranasal Sinuses of Patients with Cystic Fibrosis: CT Analysis. Amer J Rhinol. 2001;15(3):207-10.
39. Piskunov I.S., Piskunov V.S. Clinical Anatomy of Ethmoid And Sphenoid Bones And Emerging in These Sinuses. Kursk: Kursk State Medical University 2011:22-41.] (In Russ.)
40. Aitken M.L., Martinez S., McDonald G.J. et al. Sensation of smell does not determine nutrional status in patients with cystic fibrosis. Pediatr Pulmonol. 1997;24:52-56.
41. Martynova I.V., Features of Chronic Rhinosinusitis And its Clinical Significance in The Pathology of Lower Respiratory Tract Infections in Children with Cystic Fibrosis. PhD Thesis. Moscow: 2012; 25 p.] (In Russ.)
42. Polyposis Rhinosinusitis. KR-316. Clinical Recommendations. National Association of ENT. Moscow: 2016; 12 p. http://glav-otolar.ru/klinicheskie-rekomendaczii.] (In Russ.)
43. Riazantsev S.V. Etiological and Pathogenetic Principles of Therapy of Acute Sinusitis: Methodical Recommendations. St. Petersburg: Poliforum Groups 2014; 40 p.] (In Russ.)
44. Jochen G.. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis -- Results of a multicenter, prospective, randomized, double-blind, controlled trial. J Cyst Fibr. 2016;15(6):57–66.
45. Mainz J.G., Schien C., Schiller I. et al. Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial. Journal of Cystic Fibrosis. 2014;13:461-470.
46. Mainz J.G., Schädlich K., Schien C. et al. Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebocontrolled pilot study. Drug Des Devel Ther. 2014 Feb 10;8:209-17.
47. Raynor E.M., Butler A., Guill M. et al. Nasally Inhaled Dornase Alfa in the Postoperative Management of Chronic Sinusitis Due to Cystic Fibrosis. Arch Otolaryngol -- Head and Neck Surg. 2000;126:581-583.
48. Kriukov A.I., Studeny M.E., Artemiev M.E. et al. Treatment of patients with rhinosinusitis: possibilities of conservative and surgical treatment. Medical advice [Medicinskij sovet]. 2012;11:92–96.] (In Russ.)
49. Lewiston N., King V., Umetsu D. et al. Cystic fibrosis patients who have undergone heartlung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Pt 2. Transplant Proc. 1991;23(1):1207–1208.
Review
For citations:
Svistushkin VM, Sinkov EV, Shumkova GL, Amelina EL, Krasovsky SA. Features of defeat of ent organs at adult patients with CF. Meditsinskiy sovet = Medical Council. 2019;(8):48-53. (In Russ.) https://doi.org/10.21518/2079-701X-2019-8-48-53
Views:
1072
Email this article 